WATCH | Benefits of GLP-1s explored beyond weight loss: Health Canada spokesperson Marie-Pier Burelle said tirzepatide should be injected once a week and used alongside a reduced calorie diet and increased physical activity in adults with obesity, measured by a body mass index (BMI) of 30kg/m2 or higher
IGF-I is a mediator of growth hormone action
Even if that doesnt happen, doctors can use the study findings to convince patients to choose to be vaccinated
The SELECT trial was even larger, enrolling 17,604 patients with obesity and pre-existing cardiovascular disease but without diabetes
The same study also revealed semaglutides efficacy compared with placebo, with 85% of participants losing at least 5% of their baseline body weight after treatment, compared with 31.5% on the dummy medication
In recent years, medical science has made significant strides in addressing erectile dysfunction (ED) through innovative treatments